Low-Dose Ketamine Aids Chronic Refractory Pain
Treatment with low-dose ketamine was highly tolerable and improved fatigue and pain interference among patients with chronic refractory pain.
According to a study published online in Regional Anesthesia & Pain Medicine, low-dose ketamine for chronic refractory pain shows therapeutic benefit and high tolerability.
Researchers, led by Hallie Tankha, Ph.D., from the Cleveland Clinic, evaluated the effectiveness of a standardized low-dose ketamine infusion therapy (KIT) for patients with chronic refractory pain.
The analysis included 1,034 adult patients receiving KIT between May 2021 and October 2024 at an outpatient multidisciplinary pain clinic.
- Treatment completion was high (86.1 percent), with patients completing five or more infusions.
- No adverse events were reported.
Low-dose ketamine infusion therapy shows promise in managing chronic refractory pain.
Author's summary: Low-dose ketamine helps chronic pain.
More News
- Picasso portrait of muse Dora Maar in vivid hat sells for 32 million euros
- As Israeli Settlers Attack Americans, When Will We Say ‘Enough’?
- Thai Prime Minister’s statement on the passing of Her Majesty Queen Sirikit The Queen Mother - Pattaya Mail
- MDE: Chronic absenteeism is getting worse - Daily Leader
- Mattingly’s Revenge Hounds Dodgers In World Series Vs. Blue Jays
- Op-Ed: Identity Is the cybersecurity perimeter in maritime operations
- Chilling moment British man takes kids to McDonald's after murdering their parents